ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-17.63%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$237M
AUM Growth
+$237M
Cap. Flow
+$9.62M
Cap. Flow %
4.05%
Top 10 Hldgs %
95.8%
Holding
14
New
–
Increased
9
Reduced
2
Closed
–

Top Buys

1
ARWR icon
Arrowhead Research
ARWR
$5.32M
2
MRUS icon
Merus
MRUS
$4.88M
3
ARVN icon
Arvinas
ARVN
$3.22M
4
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
$1.58M
5
GMAB icon
Genmab
GMAB
$1.54M

Top Sells

1
FDMT icon
4D Molecular Therapeutics
FDMT
$6.24M
2
BPMC
Blueprint Medicines
BPMC
$3.28M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$42.2M 14.4%
1,198,515
+151,075
+14% +$5.32M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$36.2M 12.35%
716,539
-65,000
-8% -$3.28M
MRUS icon
3
Merus
MRUS
$4.98B
$33.4M 11.41%
1,477,109
+215,575
+17% +$4.88M
ARVN icon
4
Arvinas
ARVN
$568M
$32.5M 11.09%
771,745
+76,498
+11% +$3.22M
RGNX icon
5
Regenxbio
RGNX
$451M
$28.8M 9.84%
1,167,684
+49,000
+4% +$1.21M
QURE icon
6
uniQure
QURE
$896M
$18.1M 6.18%
971,490
+70,000
+8% +$1.3M
AMYT
7
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$13M 4.45%
1,866,652
+226,652
+14% +$1.58M
ARGX icon
8
argenx
ARGX
$43.6B
$9.09M 3.1%
24,000
– –
PVLA
9
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$6.99M 2.38%
3,736,280
+27,398
+0.7% +$51.2K
GMAB icon
10
Genmab
GMAB
$15.3B
$6.98M 2.38%
214,848
+47,348
+28% +$1.54M
FDMT icon
11
4D Molecular Therapeutics
FDMT
$288M
$6.01M 2.05%
861,607
-893,899
-51% -$6.24M
SPRO icon
12
Spero Therapeutics
SPRO
$116M
$3.94M 1.35%
5,321,231
+39,727
+0.8% +$29.4K
SPY icon
13
SPDR S&P 500 ETF Trust
SPY
$658B
– –
0
– –
XBI icon
14
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –